Skip to content
healthcare.dev

Naproxen Sodium (NSAID) Fever Reducer/ Pain Reliever

NDC 53746-192, Naproxen Sodium, tablet, from Amneal Pharmaceuticals of New York LLC.

Product NDC
53746-192
Status
Listed
Labeler
Amneal Pharmaceuticals of New York LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA079096
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/53746-192 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN SODIUM220 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
53746-192-0553746019205500 TABLET in 1 BOTTLE (53746-192-05)
53746-192-08537460192088 TABLET in 1 VIAL (53746-192-08)
53746-192-245374601922424 TABLET in 1 BOTTLE (53746-192-24)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 53746-192 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/53746-192 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 53746-192. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.